Cellens Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection
BOSTON–(BUSINESS WIRE)–Cellens, Inc., an early-stage cancer diagnostic company pioneering in applying mechanobiology and machine learning analysis today announced that it is collaborating with Bruker BioAFM, a business unit of Bruker(Nasdaq: BRKR), to develop the world’s first clinical diagnostic tests that leverage multi-parametric, single-cell biophysical markers and machine learning. Based on cellular biophysical markers attained using Bruker’s advanced atomic […]
LabCentral, a crucial incubator for local drug discovery, is slated to grow amid industry slowdown
For the past year, Jean Pham and a pair of employees at her three-year-old company, Cellens, shared high-tech research instruments with scores of other scientists under a LabCentral program aiding startups owned by women and people of color.MATTHEW J. LEE/GLOBE STAFF With funding constrained, some biotech startups are staying longer in shared space CAMBRIDGE — […]
CELLENS IS ON SOSV HUMAN HEALTH 100 LIST
Welcome to the second annual SOSV Human Health 100. The list captures SOSV’s 100 most exciting companies in human health as of April 2023. SOSV’s core mission, which we pursue through our IndieBio, HAX, and Orbit startup development programs, is to fund and foster startups that will improve human and planetary health. In addition to the Human Health 100, […]
CELLENS WON GOLDEN TICKET IGNITE AWARD
CAMBRIDGE, Mass., Oct. 5, 2022 /PRNewswire/ — LabCentral Ignite, with support from key sponsors Pfizer, Bristol Myers Squibb and Mission BioCapital, today announced the winners of its second annual Golden Ticket contest: Cellens, Guardian Bio, QurCan Therapeutics and Spheric Bio. The winners were unveiled at LabCentral Ignite’s bioDiversity Summit & Awards, a new annual event that brings the entire biotech ecosystem together to discuss […]
CELLENS & TUFTS UNIVERSITY TO RECEIVE “BITS TO BYTES” AWARD FROM BAKER-POLITO ADMINISTRATION AND THE MASSACHUSETTS LIFE SCIENCES CENTER
Fourteen projects receiving funding to support R&D, innovation in addressing challenges in therapeutic delivery and unlocking potential of data science to answer pressing life sciences questions. Today, the Baker-Polito Administration and the Massachusetts Life Sciences Center (MLSC) announced more than $18 million in capital funding to support 14 projects by advancing life sciences R&D, innovations […]
